Myair Inc

Our product, Airgo™ is a patented, CE certified non-invasive proxy for spirometry, sleep disorder screening (OSA, CSA, AHI, RDI, sleep staging, Cheyne–Stokes) and ICU respiratory pattern detection. We are extending its application to Covid-19 critical patient care and management (correlating Respiratory Rate, Tidal Volume and FRC) crucial in respiratory distress monitoring (ARDS). Our area of expertise is strategic monitoring of respiration dynamics during sleep and daytime activity, providing precise breath metrics, automated scoring, and early indication of respiratory distress. We are actively involved in assisting physicians in Covid-19 patient remote monitoring.